Dialysis administration of nipecotic acid to the pontine reticular nucleus, oral part (PnO) significantly increased GABA levels in the PnO. A. Representative chromatograms demonstrate excellent signal-to-noise ratios obtained during control dialysis (Ringer’s, gray line) and during dialysis administration of the GABA reuptake inhibitor nipecotic acid (NPA, black line). The increase in peak size during nipecotic acid administration confirms the presence of GABA. The inset shows a sagittal schematic modified from a rat brain atlas (Paxinos and Watson, 1998) and depicts placement of a microdialysis probe in the PnO. Arrows indicate dialysis administration of nipecotic acid via one port on the dialysis probe, and simultaneous collection of dialysis samples containing GABA via the second port on the dialysis probe. The unfilled area at the tip of the probe represents the 1 mm long dialysis membrane and is drawn to scale. B. Dialysis administration of nipecotic acid to the PnO of awake rat increased GABA levels (solid bar) to 185±20% of control (Pre-NPA Ringer’s). Control GABA levels (Pre-NPA Ringer’s) were normalized to 100% for each experiment. The number of samples analyzed for each dialysis condition was: pre-NPA Ringer’s=23, NPA=24, and post-NPA Ringer’s =22. C. A digitized image of one cresyl violet-stained coronal section illustrates a typical PnO microdialysis site located approximately 8.30 mm posterior to bregma. The arrow marks the most ventral part of the dialysis site. Note that this section was cut in a different plane from the atlas (Paxinos and Watson, 1998), and that the dorsal part of the section is more caudal than the ventral part. D. Coronal diagrams are modified from a rat brain atlas (Paxinos and Watson, 1998). Shaded cylinders represent the dialysis membranes, are drawn to scale, and show that the four dialysis sites used for the nipecotic acid study were localized to the PnO. Numbers at the top right of each brainstem schematic indicate stereotaxic coordinates in mm from bregma.